DE168293C - - Google Patents
Info
- Publication number
- DE168293C DE168293C DENDAT168293D DE168293DA DE168293C DE 168293 C DE168293 C DE 168293C DE NDAT168293 D DENDAT168293 D DE NDAT168293D DE 168293D A DE168293D A DE 168293DA DE 168293 C DE168293 C DE 168293C
- Authority
- DE
- Germany
- Prior art keywords
- barium
- weight
- mol
- parts
- salicylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003839 salts Chemical class 0.000 claims description 11
- FSVHTWITPYPMHK-UHFFFAOYSA-L barium(2+);2-carboxyphenolate Chemical compound [Ba+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O FSVHTWITPYPMHK-UHFFFAOYSA-L 0.000 claims description 3
- 235000015250 liver sausages Nutrition 0.000 claims 1
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 6
- DTDIDPVFUMHKJL-UHFFFAOYSA-N barium;2-hydroxybenzoic acid Chemical compound [Ba].OC(=O)C1=CC=CC=C1O DTDIDPVFUMHKJL-UHFFFAOYSA-N 0.000 description 5
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229960004559 theobromine Drugs 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 3
- 229910052788 barium Inorganic materials 0.000 description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- -1 theobromine barium Chemical compound 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000004552 water soluble powder Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE168293C true DE168293C (enrdf_load_stackoverflow) |
Family
ID=433531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT168293D Active DE168293C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE168293C (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE944518C (de) * | 1950-08-20 | 1956-06-14 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Loesungen von in 1, 3-Stellung substituierten Xanthinen |
-
0
- DE DENDAT168293D patent/DE168293C/de active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE944518C (de) * | 1950-08-20 | 1956-06-14 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Loesungen von in 1, 3-Stellung substituierten Xanthinen |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE168293C (enrdf_load_stackoverflow) | ||
| DE214376C (enrdf_load_stackoverflow) | ||
| DE639673C (de) | Verfahren zur Herstellung von leicht loeslichen Doppelverbindungen aus Chlorophyllinund Xanthinbasen | |
| DE694822C (de) | Verfahren zur Herstellung wasserloeslicher Doppelverbindungen von Purinen | |
| DE285579C (enrdf_load_stackoverflow) | ||
| DE929665C (de) | Verfahren zur Herstellung von therapeutisch wirksamen Streptomycin- und Dihydrostreptomycinsalzen | |
| DE633786C (de) | Verfahren zur Herstellung von Komplexverbindungen des 1, 3-Dimethylxanthins | |
| AT149825B (de) | Verfahren zur Herstellung von Alkali- bzw. Erdalkalidoppelverbindungen der Dimethylxanthine mit organischen Säuren. | |
| DE406211C (de) | Verfahren zur Darstellung von leicht loeslichen Doppelsalzen aus Monomethyl-, Dimethyl- und Trimethylxanthinen | |
| DE675674C (de) | Verfahren zur Herstellung von festen, aus der komplexen Quecksilberverbindung des salicylallylamido-essigsauren Natriums und Alkylpurinen bestehenden Molekularverbindungen | |
| CH219010A (de) | Verfahren zur Herstellung einer festen quecksilberhaltigen Molekularverbindung. | |
| AT326127B (de) | Verfahren zur herstellung von neuen, quaternierten estern der nikotinsaure mit polysacchariden | |
| DE164424C (enrdf_load_stackoverflow) | ||
| DE172932C (enrdf_load_stackoverflow) | ||
| DE2318361C2 (enrdf_load_stackoverflow) | ||
| DE858455C (de) | Verfahren zur Herstellung neutraler oder schwach saurer Loesungen von substituierten Xanthinen | |
| DE170302C (enrdf_load_stackoverflow) | ||
| DE374097C (de) | Verfahren zur Herstellung von in Wasser leicht loeslichen Doppelverbindungen aus Coffein | |
| DE3246606C2 (de) | Verfahren zur Herstellung von Salzen der Phenylhydrazin-ß-carbonsäure und deren Verwendung | |
| DE1937519A1 (de) | Stabilisierte Zusammensetzungen von Alkalimetallsalzen der OEstrogensulfate | |
| DE713079C (de) | Verfahren zur Darstellung von Abkoemmlingen der 4-Aminobenzolsulfonamide | |
| DE1041051B (de) | Verfahren zur Herstellung von Molekuelverbindungen von Purinen | |
| DE2238260B2 (de) | Phosphorsäuremonoester von 5-(2-Dimethylamlnoäthoxy)-carvacrol, Verfahren zu seiner Herstellung und diesen enthaltende Arzneimittel | |
| DE304910C (enrdf_load_stackoverflow) | ||
| DE702185C (de) | hen Calciumdoppelsalzen der Ascorbinsaeure |